Fokas, E., Prevo, R., Reaper, P., Charlton, P., Pollard, J., Mckenna, W., . . . Brunner, T. (2012). The novel ATR inhibitor VE-821 selectively sensitizes pancreatic cancer cells to radiation and chemotherapy.
Chicago Style (17th ed.) CitationFokas, E., R. Prevo, P. Reaper, P. Charlton, J. Pollard, W. Mckenna, R. Muschel, and T. Brunner. The Novel ATR Inhibitor VE-821 Selectively Sensitizes Pancreatic Cancer Cells to Radiation and Chemotherapy. 2012.
MLA (9th ed.) CitationFokas, E., et al. The Novel ATR Inhibitor VE-821 Selectively Sensitizes Pancreatic Cancer Cells to Radiation and Chemotherapy. 2012.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.